Built for regulatory confidence, consistent quality, and practical dosing in real-world FIP care.
NeoFipronis® is officially registered and distributed under regulatory oversight—providing traceability, accountability, and compliance that unregulated options cannot match.
Every batch undergoes rigorous quality testing to confirm high purity and reduce risk from unknown contaminants or inconsistent formulations.
Produced in a GMP-standard facility with controlled processes, sterile environments, and standardized quality control for reliable dosing and safety.
Each tablet contains 30mg and is designed for practical dosing. The scored format supports more accurate dose adjustment based on body weight and veterinary guidance.
NeoFipronis® is formulated for high oral bioavailability and fast onset support. Many cats may show noticeable clinical improvement within days of starting treatment, depending on disease severity and individual response.
Verified stability and packaging help protect potency during storage and transport—so you can rely on consistent quality from factory to home.
A clear comparison of regulated, pharmaceutical-grade standards versus unverified alternatives.
